Grufity logo
Grufity logo

Latest Parkman Healthcare Partners LLC Stock Portfolio

$976Million | No. of Holdings #76

Parkman Healthcare Partners LLC Performance

2026 Q2+9.52%
YTD-0.17%
2025+22.70%

About Parkman Healthcare Partners LLC and 13F Hedge Fund Stock Holdings

Parkman Healthcare Partners LLC is a hedge fund based in Stamford, CT. On 2026-08-14, the fund reported it's updated stock portfolio. In the 13F Holdings report, Parkman Healthcare Partners LLC reported an equity portfolio of $976.8 Millions as of 30 Jun, 2026. <br><br> The top stock holdings of Parkman Healthcare Partners LLC are , LLY, CVS. The fund has invested 4.5% of it's portfolio in MBX BIOSCIENCES INC and 4.3% of portfolio in ELI LILLY & CO. <br><br> The fund managers got completely rid off KALVISTA PHARMACEUTICALS INC (KALV), QIAGEN NV (QGEN) and ABBVIE INC (ABBV) stocks. They significantly reduced their stock positions in BOSTON SCIENTIFIC CORP (BSX), STRYKER CORPORATION (SYK) and WAYSTAR HLDG CORP. Parkman Healthcare Partners LLC opened new stock positions in INHIBRX BIOSCIENCES INC, UNITEDHEALTH GROUP INC (UNH) and AVALO THERAPEUTICS INC (AVTX). The fund showed a lot of confidence in some stocks as they added substantially to BRIGHT MINDS BIOSCIENCES INC (DRUG), COGENT BIOSCIENCES INC (COGT) and VIRIDIAN THERAPEUTICS INC (VRDN).
Parkman Healthcare Partners LLC Equity Portfolio Value
Last Reported on: 14 Aug, 2026
$976Million
  as of Aug 14, 2026

Parkman Healthcare Partners LLC Annual Return Estimates Vs S&P 500

Our best estimate is that Parkman Healthcare Partners LLC made a return of 9.52% in the last quarter. In trailing 12 months, it's portfolio return was 26.11%.
  • Performance
  • S&P 500

New Buys

Ticker$ Bought
inhibrx biosciences inc24,346,000
unitedhealth group inc23,242,400
indivior pharmaceuticals inc14,946,000
avalo therapeutics inc14,161,000
alto neuroscience inc11,322,200
oruka therapeutics inc10,772,100
tarsus pharmaceuticals inc9,441,000
cryoport inc7,980,690
New stocks bought by Parkman Healthcare Partners LLC

Additions

Ticker% Inc.
bright minds biosciences inc411
cogent biosciences inc153
viridian therapeutics inc146
structure therapeutics inc109
tenet healthcare corp94.08
alnylam pharmaceuticals inc88.26
4d molecular therapeutics in81.44
amneal pharmaceuticals inc79.95
Additions to existing portfolio by Parkman Healthcare Partners LLC

Reductions

Ticker% Reduced
boston scientific corp-59.78
stryker corporation-56.08
waystar hldg corp-53.96
absci corporation-52.04
optimizerx corp-51.97
livanova plc-47.88
alphatec hldgs inc-45.38
artivion inc-44.87
Parkman Healthcare Partners LLC reduced stake in above stock

Sold off

Ticker$ Sold
kalvista pharmaceuticals inc-36,948,700
accuray inc del-343,305
compass pathways plc-3,065,890
butterfly network inc-2,199,690
qiagen nv-20,020,000
cvrx inc-4,063,140
quanterix corp-1,201,920
solid biosciences inc-2,223,680
Parkman Healthcare Partners LLC got rid off the above stocks

Sector Distribution

Parkman Healthcare Partners LLC has about 79.9% of it's holdings in Healthcare sector.

  • Healthcare
  • Others
Sector%
Healthcare79.9
Others19.2

Market Cap. Distribution

Parkman Healthcare Partners LLC has about 30.2% of it's portfolio invested in the large-cap and mega-cap stocks.

  • MID-CAP
  • LARGE-CAP
  • SMALL-CAP
  • UNALLOCATED
  • MEGA-CAP
  • MICRO-CAP
Category%
MID-CAP26.8
LARGE-CAP23.5
SMALL-CAP22.5
UNALLOCATED19.2
MEGA-CAP6.7
MICRO-CAP1.1

Stocks belong to which Index?

About 65.5% of the stocks held by Parkman Healthcare Partners LLC either belong to S&P 500 or RUSSELL 2000 index.

  • RUSSELL 2000
  • Others
  • S&P 500
Index%
RUSSELL 200039
Others34.5
S&P 50026.5
Top 5 Winners (%)%
ABSI
absci corporation
211.8 %
QURE
uniqure nv
180.1 %
URGN
urogen pharma ltd
85.5 %
mbx biosciences inc
84.9 %
ENTX
entera bio ltd
58.0 %
Top 5 Winners ($)$
mbx biosciences inc
20.3 M
CVS
cvs health corp
12.3 M
ABSI
absci corporation
11.9 M
RCUS
arcus biosciences inc
9.8 M
LLY
eli lilly & co
9.7 M
Top 5 Losers (%)%
NSPR
inspiremd inc
-57.0 %
AORT
artivion inc
-30.0 %
PODD
insulet corp
-25.2 %
BSX
boston scientific corp
-22.4 %
upstream bio inc
-21.7 %
Top 5 Losers ($)$
PODD
insulet corp
-8.3 M
BSX
boston scientific corp
-6.3 M
AORT
artivion inc
-2.8 M
NSPR
inspiremd inc
-2.2 M
upstream bio inc
-1.8 M

Parkman Healthcare Partners LLC Holdings Map

This heatmap illustrates the top 50 positions within the fund's portfolio.

Current Stock Holdings of Parkman Healthcare Partners LLC

Parkman Healthcare Partners LLC has 76 stocks in it's portfolio. About 33.5% of the portfolio is in top 10 stocks. PODD proved to be the most loss making stock for the portfolio. was the most profitable stock for Parkman Healthcare Partners LLC last quarter.

$973.69MTotal Value
106Positions
14 Aug, 2026Last Reported
Current holdings of Current Stock Holdings of Parkman Healthcare Partners LLC, last reported on 14 Aug, 2026. Select a row with a linked ticker to view its historical trend.
ExpandHoldingsorted ascending% PortfolioShares Held$ Value% Change